NASDAQ:ADUSAddus Homecare Stock Price, Forecast & News

$98.65

+0.11 (+0.11 %)

(As of 06/4/2020 04:00 PM ET)

Add

Compare

Today's Range

$96.56

Now: $98.65▼

$99.06

50-Day Range

$73.92

MA: $84.61▼

$98.96

52-Week Range

$43.13

Now: $98.65▼

$104.56

Volume104,558 shs

Average Volume153,890 shs

Market Capitalization$1.53 billion

P/E Ratio51.26

Dividend YieldN/A

Beta0.51

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after surgery. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2018, the company served consumers through 156 offices located in 24 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.

Beat the Market (BTM) Rank^™

1.4 Analyst's Opinion

Consensus Rating
Addus Homecare has received a consensus rating of Buy. The company's average rating score is 2.88, and is based on 7 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $99.00, Addus Homecare has a potential upside of 0.4% from its current price of $98.65.
Amount of Analyst Coverage
Addus Homecare has only been the subject of 4 research reports in the past 90 days.

2.6 Community Rank

Outperform Votes
Addus Homecare has received 241 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Addus Homecare has received 229 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Addus Homecare has received 51.28% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Addus Homecare and other stocks. Vote “Outperform” if you believe ADUS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ADUS will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Addus Homecare does not currently pay a dividend.
Dividend Growth
Addus Homecare does not have a long track record of dividend growth.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Addus Homecare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $620,906.00 in company stock.
Percentage Held by Insiders
Only 20.10% of the stock of Addus Homecare is held by insiders.
Percentage Held by Institutions
96.04% of the stock of Addus Homecare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3 Earnings and Valuation

Earnings Growth
Earnings for Addus Homecare are expected to grow by 25.10% in the coming year, from $2.43 to $3.04 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Addus Homecare is 51.26, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.30.
Price to Earnings Ratio vs. Sector
The P/E ratio of Addus Homecare is 51.26, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.54.
Price to Earnings Growth Ratio
Addus Homecare has a PEG Ratio of 2.71. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Addus Homecare has a P/B Ratio of 4.69. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.26 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Home health care services

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:ADUS

Previous Symbol

CUSIPN/A

CIK1468328

Webwww.addus.com

Phone469-535-8200

Debt

Debt-to-Equity Ratio0.15

Current Ratio5.07

Quick Ratio5.07

Price-To-Earnings

Trailing P/E Ratio51.26

Forward P/E Ratio40.60

P/E Growth2.71

Sales & Book Value

Annual Sales$518.12 million

Price / Sales2.96

Cash Flow$2.30 per share

Price / Cash Flow42.80

Book Value$21.04 per share

Price / Book4.69

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$17.50 million

Net Margins3.35%

Return on Equity8.00%

Return on Assets5.97%

Miscellaneous

Employees33,153

Outstanding Shares15,559,000

Market Cap$1.53 billion

Next Earnings Date8/3/2020 (Estimated)

OptionableOptionable

Receive ADUS News and Ratings via Email

Sign-up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.

Addus Homecare (NASDAQ:ADUS) Frequently Asked Questions

How has Addus Homecare's stock been impacted by COVID-19 (Coronavirus)?

Addus Homecare's stock was trading at $67.64 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ADUS shares have increased by 45.8% and is now trading at $98.65. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Addus Homecare?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Addus Homecare in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Addus Homecare.

When is Addus Homecare's next earnings date?

Addus Homecare is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Addus Homecare.

How were Addus Homecare's earnings last quarter?

Addus Homecare Co. (NASDAQ:ADUS) released its earnings results on Monday, May, 4th. The company reported $0.69 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.56 by $0.13. The business had revenue of $190.20 million for the quarter, compared to analysts' expectations of $181.08 million. Addus Homecare had a return on equity of 8.00% and a net margin of 3.35%. View Addus Homecare's earnings history.

What guidance has Addus Homecare issued on next quarter's earnings?

Addus Homecare updated its first quarter 2020 After-Hours earnings guidance on Monday, May, 4th. The company provided earnings per share guidance of 0.77-0.77 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.63. The company issued revenue guidance of $190.2-190.2 million, compared to the consensus revenue estimate of $179.06 million.

What price target have analysts set for ADUS?

8 analysts have issued 12 month price objectives for Addus Homecare's shares. Their forecasts range from $85.00 to $115.00. On average, they anticipate Addus Homecare's stock price to reach $99.00 in the next twelve months. This suggests a possible upside of 0.4% from the stock's current price. View analysts' price targets for Addus Homecare.

Has Addus Homecare been receiving favorable news coverage?

News coverage about ADUS stock has been trending somewhat positive on Thursday, InfoTrie reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Addus Homecare earned a media sentiment score of 0.7 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutAddus Homecare.

Who are some of Addus Homecare's key competitors?

Some companies that are related to Addus Homecare include Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), Option Care Health (OPCH) and New York Health Care (BBAL). View all competitors.

What other stocks do shareholders of Addus Homecare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus Homecare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), Cisco Systems (CSCO), CVS Health (CVS), Ulta Beauty (ULTA), Alibaba Group (BABA) and Walt Disney (DIS).

Who are Addus Homecare's key executives?

Addus Homecare's management team includes the following people:

Mr. R. Dirk Allison, CEO, Pres & Director (Age 63)
Mr. Brian W. Poff, CFO, Exec. VP, Sec. & Treasurer (Age 45)
Mr. W. Bradley Bickham, COO & Exec. VP (Age 56)
Mr. James Zoccoli, Exec. VP & Chief Information Officer (Age 62)
Mr. Darby Anderson, Exec. VP & Chief Devel. Officer (Age 53)

What is Addus Homecare's stock symbol?

Addus Homecare trades on the NASDAQ under the ticker symbol "ADUS."

Who are Addus Homecare's major shareholders?

Addus Homecare's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (12.78%), TimesSquare Capital Management LLC (4.57%), Invesco Ltd. (4.00%), State Street Corp (2.65%), Principal Financial Group Inc. (2.47%) and Cloverdale Capital Management LLC (2.31%). Company insiders that own Addus Homecare stock include Brian Poff, Darby Anderson, David W Tucker, Eos Capital Partners Iii L P, James Zoccoli, Laurie Manning, Mark L First, R Dirk Allison, Sean Gaffney, Susan T Weaver and W Bradley Bickham. View institutional ownership trends for Addus Homecare.

Which institutional investors are selling Addus Homecare stock?

ADUS stock was sold by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, Castleark Management LLC, THB Asset Management, BlackRock Inc., TimesSquare Capital Management LLC, Russell Investments Group Ltd., Victory Capital Management Inc., and Victory Capital Management Inc.. Company insiders that have sold Addus Homecare company stock in the last year include Brian Poff, Darby Anderson, David W Tucker, Laurie Manning, Mark L First, R Dirk Allison, Sean Gaffney, Susan T Weaver, and W Bradley Bickham. View insider buying and selling activity for Addus Homecare.

Which institutional investors are buying Addus Homecare stock?

ADUS stock was acquired by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Cloverdale Capital Management LLC, Eaton Vance Management, JPMorgan Chase & Co., Nuveen Asset Management LLC, State Street Corp, Silvercrest Asset Management Group LLC, and Geode Capital Management LLC. View insider buying and selling activity for Addus Homecare.

How do I buy shares of Addus Homecare?

Shares of ADUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Addus Homecare's stock price today?

One share of ADUS stock can currently be purchased for approximately $98.65.

How big of a company is Addus Homecare?

Addus Homecare has a market capitalization of $1.53 billion and generates $518.12 million in revenue each year. Addus Homecare employs 33,153 workers across the globe.

What is Addus Homecare's official website?

The official website for Addus Homecare is www.addus.com.

How can I contact Addus Homecare?

Addus Homecare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The company can be reached via phone at 469-535-8200 or via email at [email protected]

This page was last updated on 6/4/2020 by MarketBeat.com Staff